Order Article Reprints

Ponzo M, Debesset A, Cossutta M, Chalabi-Dchar M, Houppe C, Pilon C, Nicolas-Boluda A, Meunier S, Raineri F, Thiolat A, et al. Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265. Cancers. 2022; 14(24):6160. https://doi.org/10.3390/cancers14246160

Ponzo, Matteo, Anais Debesset, Mélissande Cossutta, Mounira Chalabi-Dchar, Claire Houppe, Caroline Pilon, Alba Nicolas-Boluda, Sylvain Meunier, Fabio Raineri, Allan Thiolat, and et al. 2022. "Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265" Cancers 14, no. 24: 6160. https://doi.org/10.3390/cancers14246160

Ponzo, M., Debesset, A., Cossutta, M., Chalabi-Dchar, M., Houppe, C., Pilon, C., Nicolas-Boluda, A., Meunier, S., Raineri, F., Thiolat, A., Nicolle, R., Maione, F., Brundu, S., Cojocaru, C. F., Bouvet, P., Bousquet, C., Gazeau, F., Tournigand, C., Courty, J., ... Cascone, I. (2022). Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265. Cancers, 14(24), 6160. https://doi.org/10.3390/cancers14246160